Media coverage
2
Media coverage
Title Merck’s Pivotal Phase 3 C-EDGE Program Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses Across ... Media name/outlet World News Report Country United States Date 4/24/15 Persons Eric J Lawitz Title Merck’s Pivotal Phase 3 C-EDGE Program Evaluating Grazoprevir/Elbasvir Shows High Sustained Virologic Responses Across ... Media name/outlet EIN News Country United States Date 4/24/15 Persons Eric J Lawitz